What is AgNovos Bioscience?
AgNovos Bioscience is a privately held biopharmaceutical company dedicated to developing novel therapies for bone diseases. Leveraging proprietary bone-building technology and regenerative medicine, the company aims to address critical unmet needs in patient care. With corporate headquarters in New York City and R&D and manufacturing operations in Rockville, MD, AgNovos is positioned to advance its pipeline from discovery through to commercialization.
How much funding has AgNovos Bioscience raised?
AgNovos Bioscience has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for AgNovos Bioscience?
The substantial late-stage funding indicates AgNovos Bioscience is poised for significant expansion and the acceleration of its therapeutic development programs. This capital infusion is expected to fuel clinical trials, enhance manufacturing capabilities, and potentially support market entry strategies for its innovative bone-building technologies. The company's focus on regenerative medicine positions it to capitalize on the growing demand for advanced treatments in orthopedics and related fields.
See full AgNovos Bioscience company page
